Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,410
+280 (1.85%)
Sep 1, 2026, 3:30 PM KST

Anterogen.Co.,Ltd. Revenue

Anterogen.Co.,Ltd. had revenue of 2.20B KRW in the quarter ending June 30, 2026, with 16.53% growth. This brings the company's revenue in the last twelve months to 8.37B, up 16.55% year-over-year. In the year 2025, Anterogen.Co.,Ltd. had annual revenue of 7.54B with 8.71% growth.

Revenue (ttm)
8.37B
Revenue Growth
+16.55%
P/S Ratio
18.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
151.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.54B603.60M8.71%
Dec 31, 20246.93B432.62M6.66%
Dec 31, 20236.50B-90.76M-1.38%
Dec 31, 20226.59B-1.53B-18.85%
Dec 31, 20218.12B3.97B95.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bioneer338.01B
GC Cell163.35B
HLB Therapeutics64.45B
GC Genome32.64B
Prestige BioPharma16.21B
Genexine5.81B
iNtRON Biotechnology5.74B
MedPacto4.99B
Revenue Rankings